| __timestamp | ADMA Biologics, Inc. | Genmab A/S |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 79529000 |
| Thursday, January 1, 2015 | 6745968 | 91224000 |
| Friday, January 1, 2016 | 8494742 | 102413000 |
| Sunday, January 1, 2017 | 18092835 | 146987000 |
| Monday, January 1, 2018 | 22502922 | 213695000 |
| Tuesday, January 1, 2019 | 25910757 | 342000000 |
| Wednesday, January 1, 2020 | 35050817 | 661000000 |
| Friday, January 1, 2021 | 42896889 | 1283000000 |
| Saturday, January 1, 2022 | 52458024 | 2676000000 |
| Sunday, January 1, 2023 | 59020000 | 3297000000 |
Unlocking the unknown
In the competitive world of biotechnology, understanding financial health is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Genmab A/S and ADMA Biologics, Inc. from 2014 to 2023. Over this period, Genmab A/S has consistently outpaced ADMA Biologics, Inc. in SG&A spending, reflecting its expansive growth strategy. In 2023, Genmab's SG&A expenses soared to approximately 3.3 billion, marking a staggering 4,000% increase from 2014. Meanwhile, ADMA Biologics, Inc. saw a more modest rise, with expenses reaching nearly 59 million in 2023, a 1,100% increase from 2014. This disparity highlights Genmab's aggressive market positioning and investment in operational infrastructure. As the biotech industry continues to evolve, these financial insights offer a glimpse into the strategic priorities of these two companies.
SG&A Efficiency Analysis: Comparing Novartis AG and ADMA Biologics, Inc.
Zoetis Inc. and Genmab A/S: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: GSK plc vs ADMA Biologics, Inc.
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
Operational Costs Compared: SG&A Analysis of Genmab A/S and Axsome Therapeutics, Inc.
Cost Management Insights: SG&A Expenses for Genmab A/S and Ligand Pharmaceuticals Incorporated
SG&A Efficiency Analysis: Comparing Incyte Corporation and ADMA Biologics, Inc.
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
ADMA Biologics, Inc. vs Protagonist Therapeutics, Inc.: SG&A Expense Trends
ADMA Biologics, Inc. or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of ADMA Biologics, Inc. and Galapagos NV